William Cao is the founder of Gracell Biotechnologies. Gracell Biotechnologies has raised $520M in total funding. Latest round: IPO.
Dr. William Cao (Wei Cao) is the Co-founder and CEO of Gracell Biotechnologies, a clinical-stage biopharmaceutical company focused on developing CAR-T cell therapies. He played a key role in the company's growth, leading it through various funding stages, including an IPO on NASDAQ, and an eventual acquisition by AstraZeneca.
Full founder directory · Investor directory · Company funding database · Fundraising library